Kinarus

SW: KNRS

Market CapCHF29m

Last Close CHF0.03

Kinarus is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases.

More Kinarus content > View more
Register to receive research on Kinarus as it is published
Share price graph
Price performance
%
1m
3m
12m
Actual (3.6) (65.8) (58.8)
Relative* (4.8) (64.6) (54.3)
52-week high/low CHF0.1/CHF0.0
*% relative to local index
Key management
Dr. Alexander Bausch CEO
Subhasis Roy CFO